| Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer MM Noblejas-López, C Nieto-Jimenez, M Burgos, M Gómez-Juárez, ... Journal of Experimental & Clinical Cancer Research 38, 1-9, 2019 | 87 | 2019 |
| Glitazones induce astroglioma cell death by releasing reactive oxygen species from mitochondria: modulation of cytotoxicity by nitric oxide JM Perez-Ortiz, P Tranque, M Burgos, CF Vaquero, J Llopis Molecular pharmacology 72 (2), 407-417, 2007 | 57 | 2007 |
| CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes S Garaud, TE Taher, M Debant, M Burgos, S Melayah, C Berthou, ... Cellular & molecular immunology 15 (2), 158-170, 2018 | 55 | 2018 |
| Synthetic lethality interaction between aurora kinases and CHEK1 inhibitors in ovarian cancer A Alcaraz-Sanabria, C Nieto-Jimenez, V Corrales-Sanchez, ... Molecular cancer therapeutics 16 (11), 2552-2562, 2017 | 53 | 2017 |
| Trastuzumab-targeted biodegradable nanoparticles for enhanced delivery of dasatinib in HER2+ metastasic breast cancer E Niza, MM Noblejas-López, I Bravo, C Nieto-Jiménez, JA Castro-Osma, ... Nanomaterials 9 (12), 1793, 2019 | 47 | 2019 |
| PKCε upregulates voltage‐dependent calcium channels in cultured astrocytes M Burgos, MD Pastor, JC González, JR Martinez‐Galan, CF Vaquero, ... Glia 55 (14), 1437-1448, 2007 | 45 | 2007 |
| PKCε induces astrocyte stellation by modulating multiple cytoskeletal proteins and interacting with Rho A signalling pathways: Implications for neuroinflammation M Burgos, S Calvo, F Molina, CF Vaquero, A Samarel, J Llopis, P Tranque European Journal of Neuroscience 25 (4), 1069-1078, 2007 | 34 | 2007 |
| Caspase‐11 mediates ischemia‐induced astrocyte death: Involvement of endoplasmic reticulum stress and C/EBP homologous protein N Fradejas, MD Pastor, M Burgos, R Beyaert, P Tranque, S Calvo Journal of neuroscience research 88 (5), 1094-1105, 2010 | 28 | 2010 |
| Targeting basal-like breast tumors with bromodomain and extraterminal domain (BET) and polo-like kinase inhibitors C Nieto-Jiménez, A Alcaraz-Sanabria, J Pérez-Peña, V Corrales-Sánchez, ... Oncotarget 8 (12), 19478, 2017 | 25 | 2017 |
| Inhibition of the mitotic kinase PLK1 overcomes therapeutic resistance to BET inhibitors in triple negative breast cancer C Nieto-Jimenez, EM Galan-Moya, V Corrales-Sanchez, ... Cancer letters 491, 50-59, 2020 | 21 | 2020 |
| Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer L Serrano-Oviedo, M Nuncia-Cantarero, S Morcillo-Garcia, ... Cellular Oncology 43, 431-444, 2020 | 20 | 2020 |
| STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia M Debant, M Burgos, P Hemon, P Buscaglia, T Fali, S Melayah, ... Journal for immunotherapy of cancer 7, 1-13, 2019 | 18 | 2019 |
| Visualization of Mitochondrial Ca2+ Signals in Skeletal Muscle of Zebrafish Embryos with Bioluminescent Indicators M Vicente, J Salgado-Almario, J Soriano, M Burgos, B Domingo, J Llopis International Journal of Molecular Sciences 20 (21), 5409, 2019 | 18 | 2019 |
| Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis M Burgos, I Cavero-Redondo, C Álvarez-Bueno, EM Galán-Moya, ... Therapeutic Advances in Medical Oncology 14, 17588359211072621, 2022 | 16 | 2022 |
| A proteomic analysis of PKCε targets in astrocytes: Implications for astrogliosis M Burgos, N Fradejas, S Calvo, SU Kang, P Tranque, G Lubec Amino Acids 40, 641-651, 2011 | 15 | 2011 |
| Antitumoral activity of a CDK9 PROTAC compound in HER2-positive breast cancer MM Noblejas-López, L Gandullo-Sánchez, EM Galán-Moya, ... International Journal of Molecular Sciences 23 (10), 5476, 2022 | 14 | 2022 |
| MZ1 co-operates with trastuzumab in HER2 positive breast cancer MM Noblejas-López, C Nieto-Jiménez, EM Galán-Moya, D Tebar-García, ... Journal of Experimental & Clinical Cancer Research 40, 1-12, 2021 | 14 | 2021 |
| Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple‐negative breast cancer V Corrales‐Sánchez, MM Noblejas‐López, C Nieto‐Jiménez, ... Journal of Cellular and Molecular Medicine 24 (5), 3117-3127, 2020 | 14 | 2020 |
| Crocetin isolated from the natural food colorant saffron reduces intracellular fat in 3T3-L1 adipocytes E Jiménez-Ortega, A Braza-Boïls, M Burgos, N Moratalla-López, ... Foods 9 (11), 1648, 2020 | 11 | 2020 |
| Checkpoint kinase 1 pharmacological inhibition synergizes with DNA-damaging agents and overcomes platinum resistance in basal-like breast cancer C Nieto-Jimenez, A Alcaraz-Sanabria, S Martinez-Canales, ... International Journal of Molecular Sciences 21 (23), 9034, 2020 | 7 | 2020 |
